79 related articles for article (PubMed ID: 29199252)
1. [Evaluation of Pharmacotherapy on Emergency and Intensive Care Medicine: The Influence of Intensity and Duration of Invasion].
Imai T
Yakugaku Zasshi; 2017; 137(12):1427-1430. PubMed ID: 29199252
[TBL] [Abstract][Full Text] [Related]
2. [Influence of systemic inflammatory response syndrome on the pharmacokinetics of vancomycin].
Irikuchi J; Imai T; Yoshida Y; Orii T
Yakugaku Zasshi; 2015; 135(5):745-51. PubMed ID: 25948312
[TBL] [Abstract][Full Text] [Related]
3. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
[TBL] [Abstract][Full Text] [Related]
4. [Validating the Effectiveness of Switching the Vancomycin TDM Analysis Software Based on the Predictive Accuracy].
Imai S; Yamada T; Ishiguro N; Miyamoto T; Kagami K; Tomiyama N; Niinuma Y; Nagasaki D; Suzuki K; Yamagami A; Kasashi K; Kobayashi M; Iseki K
Yakugaku Zasshi; 2017; 137(9):1185-1192. PubMed ID: 28867705
[TBL] [Abstract][Full Text] [Related]
5. [Involvement of Pharmacists in Medical Care in Emergency and Critical Care Centers].
Imai T; Yoshida Y
Yakugaku Zasshi; 2016; 136(7):967-72. PubMed ID: 27374959
[TBL] [Abstract][Full Text] [Related]
6. Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin.
Hirai K; Ishii H; Shimoshikiryo T; Shimomura T; Tsuji D; Inoue K; Kadoiri T; Itoh K
Ther Drug Monit; 2016 Dec; 38(6):706-710. PubMed ID: 27681114
[TBL] [Abstract][Full Text] [Related]
7. The admission systemic inflammatory response syndrome predicts outcome in patients undergoing emergency surgery.
Chao A; Chou WH; Chang CJ; Lin YJ; Fan SZ; Chao AS
Asian J Surg; 2013 Jul; 36(3):99-103. PubMed ID: 23810158
[TBL] [Abstract][Full Text] [Related]
8. Switching From Intermittent to Continuous Infusion of Vancomycin in Critically Ill Patients: Toward a More Robust Exposure.
van Maarseveen EM; Gipmans S; Vasbinder E; Petjak M; van Zanten AR
Ther Drug Monit; 2016 Jun; 38(3):398-401. PubMed ID: 26926670
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
10. Impact of vancomycin therapeutic drug monitoring on patient care.
Welty TE; Copa AK
Ann Pharmacother; 1994 Dec; 28(12):1335-9. PubMed ID: 7696720
[TBL] [Abstract][Full Text] [Related]
11. [A study on phenytoin pharmacokinetics in 15 patients with refractory epilepsy].
Pan SQ; Hu ZX; Cai HS
Zhonghua Nei Ke Za Zhi; 1992 May; 31(5):290-2, 318. PubMed ID: 1478128
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.
Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V
Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of systemic inflammatory response syndrome and multiple organ dysfunction syndrome in critically patients].
Qiu H; Du B; Liu D
Zhonghua Wai Ke Za Zhi; 1997 Jul; 35(7):402-5. PubMed ID: 10677973
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation.
Wu CC; Shen LJ; Hsu LF; Ko WJ; Wu FL
J Formos Med Assoc; 2016 Jul; 115(7):560-70. PubMed ID: 26123638
[TBL] [Abstract][Full Text] [Related]
15. Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.
Nakano T; Nakamura Y; Takata T; Irie K; Sano K; Imakyure O; Mishima K; Futagami K
Int J Clin Pharm; 2016 Aug; 38(4):908-14. PubMed ID: 27125378
[TBL] [Abstract][Full Text] [Related]
16. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application.
Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C;
J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome.
Simon L; Saint-Louis P; Amre DK; Lacroix J; Gauvin F
Pediatr Crit Care Med; 2008 Jul; 9(4):407-13. PubMed ID: 18496408
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Fasting and Massive Diarrhea on Absorption of Enteral Vancomycin in Critically Ill Patients: A Retrospective Observational Study.
Oami T; Hattori N; Matsumura Y; Watanabe E; Abe R; Oshima T; Takahashi W; Yamazaki S; Suzuki T; Oda S
Front Med (Lausanne); 2017; 4():70. PubMed ID: 28642864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
